Takwa Wannassi | Plant pathology | Best Researcher Award

Published on by Cell Biologist

Dr. Takwa Wannassi | Plant pathology | Best Researcher Award

Dr. Takwa Wannassi, CRRA Sidi Bouzid, Tunisia

Dr. Takwa Wannassi is a dedicated plant protection specialist and postdoctoral researcher at the Regional Center of Agricultural Research in Sidi Bouzid, Tunisia. With a Ph.D. in Plant Protection and Environment and an Engineering Degree in Horticulture, she brings advanced expertise in entomology, plant-microbe interactions, and sustainable agriculture. Her work is primarily focused on integrated pest management and ecological approaches to crop protection, particularly in Mediterranean agroecosystems. Dr. Wannassi has authored several impactful scientific publications and has contributed significantly to the understanding of invasive pest dynamics, particularly the apricot seed wasp. She plays a crucial role in the international PRIMA project “REVINE,” where she coordinates field trials, mentors students, and collaborates across scientific disciplines. Her dedication to sustainable farming solutions, her extensive research record, and her collaborative spirit make her a strong candidate for the Best Researcher Award.

Publication Profile: 

Google Scholar
Scopus
Orcid

Education:

Dr. Takwa Wannassi holds a Ph.D. in Plant Protection and Environment from Sousse University, Higher Institute of Agronomic Sciences of Chott Mariem (ISA-CM), completed in December 2022. Her doctoral work centered on invasive species and sustainable pest management in Tunisia, particularly the apricot seed wasp Eurytoma samsonowi. She also holds an Engineer Degree in Horticulture with a specialization in Plant Protection, earned in July 2017 from the same institution. Her academic journey reflects a consistent focus on understanding ecological challenges in agriculture and developing innovative, sustainable solutions. Through both degrees, she acquired hands-on skills in molecular biology, field experimentation, pest identification, and biological control. Her academic excellence laid the foundation for her impactful contributions in agricultural research and sustainability science in the Mediterranean region.

Experience:

Since January 2025, Dr. Takwa Wannassi has been serving as a postdoctoral fellow at the Regional Center of Agricultural Research in Sidi Bouzid (CRRA), Tunisia, contributing to the international PRIMA Project “REVINE.” Her responsibilities include coordinating the research project, supervising graduate students, conducting field and lab trials, and analyzing data using R. Her work spans genomic analysis, molecular diagnostics, pest ecology, and microbiome studies. Previously, during her Ph.D., she gained extensive experience in pest ecology, molecular biology, and entomology, particularly in relation to invasive pests such as Eurytoma samsonowi. Dr. Wannassi also collaborates with international institutions, including during a research fellowship in Canada. She is proficient in preparing scientific publications and has presented her findings at major international conferences. Her multidisciplinary approach and leadership in sustainable agriculture research have earned her recognition at both national and international levels.

Awards and Honors:

Dr. Takwa Wannassi has received several accolades in recognition of her contributions to agricultural science and research. In 2019, she earned the Best Poster Award at the Tunisia-Japan Symposium on Science, Society and Technology (TJASSST) for her research on pest behavior and pheromone-based management strategies. That same year, she was granted a Research Fellowship in Canada, allowing her to work at the University of Victoria, British Columbia for two months, enhancing her international research exposure and collaboration. Her continuous efforts in sustainable pest management, microbiome studies, and plant-pathogen interaction have positioned her as a promising researcher in plant protection. She is frequently invited to contribute to scientific conferences and peer-reviewed journals. Her achievements underline her scientific innovation, dedication to eco-agriculture, and her potential as a future leader in Mediterranean agricultural research.

Research Focus:

Dr. Takwa Wannassi’s research centers on plant protection, pest ecology, biological control, and plant-microbiome interactions, with a strong focus on sustainability. Her main scientific interest lies in understanding the behavior and biology of invasive pests like Eurytoma samsonowi, a major threat to apricot production in Tunisia. She utilizes molecular tools, including 16S rRNA sequencing, to explore bacterial communities and Wolbachia infections in pest populations. Additionally, she investigates the role of beneficial rhizobacteria and microbial consortia in disease suppression and grapevine health as part of the PRIMA “REVINE” project. Through multidisciplinary approaches, she integrates entomology, microbiology, and bioinformatics to develop innovative pest management strategies aligned with climate-smart agriculture. Her goal is to promote ecosystem services, biodiversity, and resilience in Mediterranean cropping systems through regenerative and eco-friendly practices.

Publications Top Notes: 

  1. Insights on the bioecology of the invasive apricot seed wasp Eurytoma samsonowi in Tunisia (Biologia, 2023)

  2. Emergence of the apricot seed wasp Eurytoma samsonowi as an economic pest of apricots in Tunisia (Phytoparasitica, 2022)

  3. Prevalence of Wolbachia infection in field populations of the apricot seed wasp (International Microbiology, 2024)

  4. Exploration of bacterial composition and diversity within Eurytoma samsonowi via 16S rRNA sequencing (Symbiosis, 2025)

  5. Harnessing a Microbial Consortium and Compost to Control Grapevine Pathogens (Horticulturae, 2025)

  6. Investigating the potential role of beneficial rhizobacteria for grapevine health and growth (Frontiers in Sustainable Food Systems, 2025)

  7. Biocontrol Assessment of Trichoderma Species on Tomato Crops Infested by Curvularia Spicifera (Frontiers, 2025)

  8. Divergent bacterial abundance and diversity in Eurytoma samsonowi revealed by 16S rRNA (Biochem & Microbiology Congress)

  9. Assessment of damage by Eurytoma samsonowi on apricot fruits in Tunisia (INAT Symposium Poster, 2018)

  10.  Delta traps with virgin females attract Eurytoma samsonowi males: Pheromone control potential (TJASSST, 2019)

Conclusion:

Dr. Takwa Wannassi is an emerging leader in plant protection and agroecology, with a proven record of excellence in research, publishing, and project management. Her work on invasive pest control, microbial consortia, and regenerative viticulture directly addresses critical challenges in Mediterranean and global agriculture. Her multidisciplinary approach, international recognition, and active mentorship highlight her readiness for continued leadership in science. She is highly suitable and deserving of the Best Researcher Award, as she exemplifies innovation, academic rigor, and a commitment to sustainable agricultural development.

Raphael Borie | Gene Regulation Epigenetics | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Raphael Borie | Gene Regulation Epigenetics | Best Researcher Award

Prof. Dr. Raphael Borie, APHP, France

Dr. Raphaël Borie, born on August 15, 1977, in Paris, France, is a leading expert in pulmonology and genetic respiratory diseases. Currently a University Professor Hospital Practitioner at Bichat Hospital (Paris Cité University), he has consistently contributed to the advancement of respiratory medicine, particularly in the field of interstitial lung diseases (ILDs). His clinical insight, combined with a strong research portfolio, has positioned him as a prominent figure within the OrphaLung network. A dedicated family man with two children, Dr. Borie is widely respected for his integrity, leadership, and commitment to collaborative medicine. His career reflects a unique blend of academic excellence and impactful translational research, bridging the gap between genomics and clinical care in ILD. He is a registered member of the French Medical Council (Ordre des Médecins No. 75/71138), and his research has influenced European clinical guidelines and improved the understanding of rare genetic pulmonary conditions.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Robust Academic Background:
    Dr. Borie holds a PhD in Genetics, Master’s in Physiology, and HDR (habilitation to supervise doctoral research), which underlines his scientific credibility and ability to lead independent research.

  2. Clinical-Research Integration:
    As a University Professor and Hospital Practitioner, he merges frontline patient care with cutting-edge genetic and respiratory disease research.

  3. High Publication Impact:
    With 283 PubMed-indexed articles and an H-index of 60, Dr. Borie’s work demonstrates strong citation influence, indicating widespread recognition and utility in the scientific community.

  4. International Leadership:
    Active in multinational collaborations (e.g., OrphaLung, ERS), he has co-authored major position statements and clinical trials, influencing European respiratory care guidelines.

  5. Innovation in Rare Diseases:
    A recognized expert in familial interstitial lung disease and telomere disorders, his work has led to earlier diagnosis and targeted therapies—critical in fields where few experts exist.

  6. Recognition and Funding:
    He has secured prestigious mobility grants (ERS, Respirology Teachers College)—a marker of trust in his scientific mission and innovation.

🔍 Areas for Improvement:

  • Wider Public Health Translation: While Dr. Borie’s genomic research is exceptional, expanding into real-world health policy implementation could enhance systemic impact.

  • Patient Engagement & Advocacy: Developing patient-oriented tools or registries (e.g., digital apps or platforms for familial lung diseases) may broaden his outreach beyond academia and clinics.

  • Broader Visibility: Although highly cited in professional circles, participation in international keynote talks, editorial leadership, or mainstream health media could elevate his public and professional visibility.

🎓 Education:

Dr. Borie has pursued an extensive and rigorous academic path focused on respiratory and genetic medicine. He obtained his medical degree with specialization in Allergology and Immunopathology in 2006. A year earlier, in 2005, he earned a Master’s degree in Biology and Physiology of Circulation and Respiration. Demonstrating deep interest in genetics, he completed a PhD in Genetics in 2017, contributing significantly to our understanding of genetic underpinnings in pulmonary fibrosis. In 2019, Dr. Borie achieved the prestigious Habilitation à Diriger des Recherches (HDR) from the University of Paris 7, enabling him to supervise doctoral research. His academic background illustrates a powerful integration of clinical expertise and molecular research—providing him with the tools to lead innovative research projects at the intersection of genomics and pulmonology.

🩺 Experience:

Dr. Raphaël Borie has over 15 years of experience in respiratory medicine. From July 2011 to August 2020, he served as a Hospital Practitioner in the Pneumology Department at Bichat Hospital under Professors Aubier and Crestani. Since September 2020, he has been a University Professor Hospital Practitioner in the same department, affiliated with Paris Cité University. He has contributed to patient care, education of medical students and residents, and cutting-edge research. As part of the OrphaLung network, he plays a critical role in advancing diagnostic tools and treatment approaches for rare lung diseases. He is recognized for his collaborative leadership and interdisciplinary contributions across genetics, immunology, and pulmonology. His international collaborations and authorship of over 280 PubMed-indexed publications demonstrate his ongoing commitment to improving patient outcomes through translational research.

🏆 Awards and Honors:

Dr. Borie’s research excellence has been recognized through several prestigious awards and scholarships. In 2017, he received the European Respiratory Society (ERS) Mobility Grant for his work on Identification of Preclinical Markers of Pulmonary Fibrosis, supporting international collaboration and advanced training. The same year, he was also honored with the Respirology Teachers College Mobility Grant, reinforcing his pioneering research on early detection of fibrotic lung disease. His selection for these awards highlights both scientific innovation and dedication to knowledge exchange. His leadership in multi-center studies and involvement in ERS guideline statements further reflect his status as a thought leader in interstitial lung disease. These honors are a testament to his influence in shaping the future of pulmonary genetics and translational respiratory medicine.

🔬 Research Focus:

Dr. Raphaël Borie’s research centers on familial and genetic interstitial lung diseases, particularly the molecular mechanisms behind pulmonary fibrosis, telomere biology, surfactant-related gene variants, and early detection strategies. He works extensively on identifying genetic risk variants (e.g., MUC5B, DSP) and their implications in idiopathic pulmonary fibrosis. Through his participation in the OrphaLung network, he supports genomic screening for hereditary lung disorders and contributes to developing European guidelines. His work bridges genomic medicine and clinical pulmonology, aiming for earlier diagnosis and personalized treatment approaches. He has led and co-authored critical studies on RTEL1 mutations, telomerase complex defects, and familial ILD phenotypes, helping clinicians globally understand the heterogeneity and systemic implications of genetic lung disorders. His collaborative international research ensures his findings are applied in practice to optimize long-term patient care.

📚Publications Top Notes:

  • 🧬 High risk of lung cancer in surfactant-related gene variant carriers – Eur Respir J, 2024

  • 📄 European Respiratory Society Statement on Familial Pulmonary Fibrosis – Eur Respir J, 2022

  • 🧪 Colocalization of Gene Expression and DNA Methylation with Genetic Risk Variants – Am J Respir Crit Care Med, 2022

  • 🧬 RTEL1 mutations and their phenotypic variability – Eur Respir J, 2019

  • 💊 Safety and efficacy of pirfenidone in telomerase mutation carriers – Eur Respir J, 2018

  • 🌐 Diagnosis and follow-up of familial ILD: International survey – BMC Pulmonary Med, 2025

  • 🧬 New 2023 ACR/EULAR APS criteria performance in young patients – Letter, 2025

  • 🫁 A non-resolving cough: a case of familial pulmonary fibrosis – Breathe, 2025

  • 🧬 PFMG2025: Genomic medicine in French healthcare system – Review, 2025

  • 💊 Efficacy of CFTR modulators in ABCA3-deficiency ILD – Open Access, 2025

  • 🧠 Neurological manifestations in VEXAS syndrome – Journal of Neurology, 2025

  • 💉 Real-life use of PEXIVAS reduced-dose regimen in vasculitis – Ann Rheum Dis, 2025

  • 🧫 Recurrent respiratory papillomatosis with lung involvement – Eur Respir J, 2025

  • 🔍 RA-ILD: genetics to clinical overview – Review, 2025

  • 👶 Childhood ILD survivors in adulthood: European study – Eur Respir J, 2025

🧾 Conclusion:

Dr. Raphaël Borie exemplifies the ideal candidate for the Best Researcher Award. His excellence spans across clinical expertise, academic distinction, and international research leadership, especially in genetic and familial interstitial lung diseases—a field with enormous unmet need. His consistent scholarly output, impactful collaborations, and patient-focused studies highlight a unique blend of depth and innovation. While further expansion into public health frameworks and patient engagement tools would be valuable, his profile already reflects a world-class researcher with transformative contributions to pulmonary medicine.